Skip to Main Content
Phase II

Combining Varenicline and Guanfacine for Smoking Cessation

  • Study HIC#:2000026630
  • Last Updated:11/11/2022

In this study, we are looking at how the medications Varenicline and Guanfacine can be used to treat smoking. Participants will receive either Varenicline or Varenicline plus Guanfacine.

  • Age18 years and older
  • GenderBoth
  • Start Date02/11/2020
  • End Date09/30/2020

Eligibility Criteria

Eligibility criteria

  • Age 18+
  • Able to read and write English
  • SMOKER: 10 or more cigarettes per day for at least the past year
  • Able to take oral medications and willing to adhere to medication regimen 
  • Motivated to quit smoking

Principal Investigator


For more information about this study, contact:

Or contact the Help us Discover team on: